Skip to main content
Image of syringe and pipets)

Therapeutic Areas and Products

Hematology

Factor XIII Deficiency

Overview

Congenital factor XIII deficiency is an autosomal recessive disorder.

Acquired factor XIII deficiency can be seen in the setting of cardiac surgery, malignancy, infection and irritable bowel disease.

Caused by mutations in the genes that code for either FVIII subunit A or B (rarer).

Clinical Presentation

Most common bleeding sites include umbilical stump, soft tissue, surgical and intracranial.

Poor wound healing is often present.

Diagnosis

Measure FXIII activity.

PT, aPTT, and thrombin time are usually normal.
Genetic analysis to identify gene mutation.

Treatment

Prophylaxis recommended especially with levels <10%

1. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia. (6)2008;14:1190-1200. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2008.01857.x/pdf

For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional